Vertex Pharmaceuticals (VRTX) SG&A Expense Growth & History | Stock Alarm

Demo Sign up Log In

Vertex Pharmaceuticals · SG&A Expense Growth

VRTX SG&A Expense Growth

Latest reported19.72%period endingDec 31, 2025

VRTX FY SG&A Growth (YoY) (0.00% → 19.72%)

Latest values, visible window

High-resolution chart · PNG

VRTX sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals SG&A Expense Growth — Annual fiscal periods
Period ending	SG&A Expense Growth
Dec 31, 2025	19.7227%
Dec 31, 2024	28.8316%
Dec 31, 2023	20.3133%
Dec 31, 2022	12.4509%
Dec 31, 2021	9.0331%
Dec 31, 2020	17.0087%
Dec 31, 2019	18.0917%
Dec 31, 2018	12.4047%
Dec 31, 2017	14.6132%
Dec 31, 2016	14.7844%
Dec 31, 2015	23.4672%
Dec 31, 2014	-15.7125%
Dec 31, 2013	-17.0455%
Dec 31, 2012	9.0025%
Dec 31, 2011	113.3765%
Dec 31, 2010	45.247%
Dec 31, 2009	26.8737%
Dec 31, 2008	20.2804%
Dec 31, 2007	46.4345%
Dec 31, 2006	31.5299%
Dec 31, 2005	4.3926%
Dec 31, 2004	7.822%
Dec 31, 2003	-20.8706%
Dec 31, 2002	4.337%
Dec 31, 2001	70.2402%
Dec 31, 2000	6.5364%
Dec 31, 1999	44.1989%
Dec 31, 1998	58.7719%
Dec 31, 1997	44.3038%
Dec 31, 1996	11.2676%
Dec 31, 1995	-82.3821%
Dec 31, 1994	50.9363%
Dec 31, 1993	93.4783%
Dec 31, 1992	56.8182%
Dec 31, 1991	37.5%
Dec 31, 1990	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.